口服NK1拮抗剂阿瑞吡坦预防接受高度致吐性化疗患者的恶心和呕吐

{"title":"口服NK1拮抗剂阿瑞吡坦预防接受高度致吐性化疗患者的恶心和呕吐","authors":"R. Wit, P. Hesketh, D. Warr, K. Petty, A. Carides, Judith K. Evans, T. Simon, K. Horgan","doi":"10.2165/00024669-200504010-00003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7698,"journal":{"name":"American Journal of Cancer","volume":"402 1","pages":"35-48"},"PeriodicalIF":0.0000,"publicationDate":"2005-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"14","resultStr":"{\"title\":\"The Oral NK1 Antagonist Aprepitant for Prevention of Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy\",\"authors\":\"R. Wit, P. Hesketh, D. Warr, K. Petty, A. Carides, Judith K. Evans, T. Simon, K. Horgan\",\"doi\":\"10.2165/00024669-200504010-00003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7698,\"journal\":{\"name\":\"American Journal of Cancer\",\"volume\":\"402 1\",\"pages\":\"35-48\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2165/00024669-200504010-00003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00024669-200504010-00003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}